
Oluwatosin Adesoye
Articles
-
1 week ago |
sicklecellanemianews.com | Steve Bryson |Oluwatosin Adesoye |Esteban Cerezo |Andrea Lobo
Women with sickle cell disease (SCD) have markedly elevated levels of C-reactive protein (CRP), a marker of body-wide inflammation, during the first half of their menstrual cycles, and these variations may contribute to recurrent patterns of vaso-occlusive events (VOEs), complications resulting from blood vessel obstruction that include painful vaso-occlusive crises. a study found.
-
4 weeks ago |
sicklecellanemianews.com | Oluwatosin Adesoye |Dunstan Nicol-Wilson
As I look back on my two-year journey as a sickle cell disease columnist for Bionews, the parent company of this website, I’m struck by how much I’ve grown and evolved. In fact, I’m extremely proud. It all began in late 2022, when I stumbled upon a job posting on LinkedIn that sought a columnist to write about sickle cell disease.
-
1 month ago |
sicklecellanemianews.com | Margarida Maia |Oluwatosin Adesoye |Mary Shaniqua |Dunstan Nicol-Wilson
People with sickle cell disease (SCD) who are hospitalized for opioid overdose have fewer serious complications than those without the condition, but face longer hospital stays, higher costs, and unique healthcare challenges that require specialized care, a study found. “A multidisciplinary approach to pain management, tailored to individual patient needs and aligned with established guidelines, is crucial for improving outcomes and reducing complications in SCD,” they wrote.
-
1 month ago |
sicklecellanemianews.com | Oluwatosin Adesoye |Sylvia Amuta |Mary Shaniqua |Dunstan Nicol-Wilson
Recently, I’ve been reflecting on how living with sickle cell disease has affected many of my dreams, goals, and lifestyle choices. Despite the changes, I have continued to dream and pursue my aspirations successfully. The impact of sickle cell disease intensified for me during my early 20s. As a result, my journey through medical school became more stressful than anticipated, transforming it into a story of resilience, determination, and persistence.
-
1 month ago |
sicklecellanemianews.com | Lindsey Shapiro |Oluwatosin Adesoye |Marisa Wexler |Andrea Lobo
Most people with sickle cell disease (SCD) who received a new type of stem cell transplant in a clinical trial were free of disease-related clinical events after two years, according to a study.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →